Windtree Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview

Windtree Therapeutics

07/08/2023 12:59

* Windtree Therapeutics Inc  WINT.OQ   WINT.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 9 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Windtree
Therapeutics Inc
is for a loss of 68 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $5​, above​ its last closing price of $1.32.
​​​

This summary was machine generated August 7 at 11:59 GMT.  All
figures in US dollars  unless otherwise stated